BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 23322901)

  • 21. Retinoic acid protects human breast cancer cells against etoposide-induced apoptosis by NF-kappaB-dependent but cIAP2-independent mechanisms.
    Jiménez-Lara AM; Aranda A; Gronemeyer H
    Mol Cancer; 2010 Jan; 9():15. PubMed ID: 20102612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinoids and their receptors in cancer development and chemoprevention.
    Sun SY; Lotan R
    Crit Rev Oncol Hematol; 2002 Jan; 41(1):41-55. PubMed ID: 11796231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinoids as differentiating agents in oncology: a network of interactions with intracellular pathways as the basis for rational therapeutic combinations.
    Garattini E; Gianni M; Terao M
    Curr Pharm Des; 2007; 13(13):1375-400. PubMed ID: 17506722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclin proteolysis as a retinoid cancer prevention mechanism.
    Dragnev KH; Freemantle SJ; Spinella MJ; Dmitrovsky E
    Ann N Y Acad Sci; 2001 Dec; 952():13-22. PubMed ID: 11795432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor-alpha acquire sensitivity to growth inhibition by retinoids.
    Sheikh MS; Shao ZM; Li XS; Dawson M; Jetten AM; Wu S; Conley BA; Garcia M; Rochefort H; Fontana JA
    J Biol Chem; 1994 Aug; 269(34):21440-7. PubMed ID: 8063776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinoids as chemopreventive agents.
    Ralhan R; Kaur J
    J Biol Regul Homeost Agents; 2003; 17(1):66-91. PubMed ID: 12757022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of retinoic acid receptor beta in head and neck squamous cell carcinoma cells increases their sensitivity to retinoid-induced suppression of squamous differentiation by retinoids.
    Wan H; Oridate N; Lotan D; Hong WK; Lotan R
    Cancer Res; 1999 Jul; 59(14):3518-26. PubMed ID: 10416619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinoids in chemoprevention and differentiation therapy.
    Hansen LA; Sigman CC; Andreola F; Ross SA; Kelloff GJ; De Luca LM
    Carcinogenesis; 2000 Jul; 21(7):1271-9. PubMed ID: 10874003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. All-trans retinoic acid converts E2F into a transcriptional suppressor and inhibits the growth of normal human bronchial epithelial cells through a retinoic acid receptor- dependent signaling pathway.
    Lee HY; Dohi DF; Kim YH; Walsh GL; Consoli U; Andreeff M; Dawson MI; Hong WK; Kurie JM
    J Clin Invest; 1998 Mar; 101(5):1012-9. PubMed ID: 9486971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro.
    Shiohara M; Dawson MI; Hobbs PD; Sawai N; Higuchi T; Koike K; Komiyama A; Koeffler HP
    Blood; 1999 Mar; 93(6):2057-66. PubMed ID: 10068679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of chromosome 3p deletion on the expression of the putative tumor suppressor RAR beta and on retinoid resistance in human squamous carcinoma cells.
    Zou CP; Youssef EM; Zou CC; Carey TE; Lotan R
    Oncogene; 2001 Oct; 20(47):6820-7. PubMed ID: 11687961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How retinoids regulate breast cancer cell proliferation and apoptosis.
    Simeone AM; Tari AM
    Cell Mol Life Sci; 2004 Jun; 61(12):1475-84. PubMed ID: 15197471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of receptor-selective retinoids on growth and differentiation pathways in mouse melanoma cells.
    Desai SH; Boskovic G; Eastham L; Dawson M; Niles RM
    Biochem Pharmacol; 2000 May; 59(10):1265-75. PubMed ID: 10736427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinoic acid receptors and cancers.
    Soprano DR; Qin P; Soprano KJ
    Annu Rev Nutr; 2004; 24():201-21. PubMed ID: 15189119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retinoid therapy of childhood cancer.
    Reynolds CP; Lemons RS
    Hematol Oncol Clin North Am; 2001 Oct; 15(5):867-910. PubMed ID: 11765378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways.
    Defacque H; Sévilla C; Piquemal D; Rochette-Egly C; Marti J; Commes T
    Leukemia; 1997 Feb; 11(2):221-7. PubMed ID: 9009084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fenretinide-induced apoptosis of Huh-7 hepatocellular carcinoma is retinoic acid receptor beta dependent.
    Bu P; Wan YJ
    BMC Cancer; 2007 Dec; 7():236. PubMed ID: 18166136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of retinoic acid receptor-gamma selectively binding retinoids alone and in combination with interferon-gamma in breast cancer cell lines.
    Widschwendter M; Daxenbichler G; Culig Z; Michel S; Zeimet AG; Mörtl MG; Widschwendter A; Marth C
    Int J Cancer; 1997 May; 71(3):497-504. PubMed ID: 9139890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptor selective synthetic retinoids as potential cancer chemotherapy agents.
    Crowe DL
    Curr Cancer Drug Targets; 2002 Mar; 2(1):77-86. PubMed ID: 12188922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retinoids and rexinoids in cancer prevention: from laboratory to clinic.
    Uray IP; Dmitrovsky E; Brown PH
    Semin Oncol; 2016 Feb; 43(1):49-64. PubMed ID: 26970124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.